PTK2B and acute myeloid leukemia: 2.7. In Cytogenetic IR-AML Patients with Non-Favorable FLT3/NPM1 Combinations and PTK2B or LYN Underexpression, PTK2 Overexpression Identify a Subgroup with Unfavorable OS and DFS